Skip to main content
TipRanks
Go Ultimate75% OFF

RedHill Biopharma (RDHL) Q3 2018 Earnings Report

904 Followers

RDHL Q3 2018 EPS Results

Actual EPS
-$0.40
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$0.90

RDHL Q3 2018 Revenue Results

Actual Revenue
$2.21M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2018
Date
11/13/2018
Time
TBA
Conference Call
Tuesday, November 13, 2018
RDHL Upcoming Earnings

RedHill Biopharma's next earnings date is estimated for March 18, 2027, based on past reporting schedules.

Q3 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

RDHL Earnings History

RDHL earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 18, 20272026 (Q4)―-―――
Sep 30, 20262026 (Q2)―-1.01-2.3256.56% (+1.31)
Apr 27, 20262025 (Q4)―-――
Sep 05, 20252025 (Q2)―-2.320―
May 13, 20252025 (Q1)―-――
Apr 10, 20252024 (Q4)―-――
Aug 29, 20242024 (Q2)―0.001-100.00% (-1.00)
May 07, 20242024 (Q1)―-――
Apr 08, 20242023 (Q4)―--0.05―
Nov 15, 20232023 (Q3)―0.04-2.4101.67% (+2.44)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed